S&P 500 (NYSE:SPY) component Boston Scientific Corporation (NYSE:BSX) will unveil its latest earnings on Monday, July 18, 2011. Boston Scientific, Inc. offers medical devices used in interventional cardiology, cardiac rhythm management, peripheral interventions, endoscopy, gynecology, electrophysiology, neurovascular intervention and neuromodulation.
Boston Scientific Corporation Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 8 cents per share, a rise of 33.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 7 cents. For the year, analysts are projecting net income of 40 cents per share, a decline of 16.7% from last year.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 10 cents, reporting profit of 14 cents per share against a mean estimate of net income of 4 cents per share.
Wall St. Revenue Expectations: On average, analysts predict $1.94 billion in revenue this quarter, a rise of 0.5% from the year ago quarter. Analysts are forecasting total revenue of $7.74 billion for the year, a decline of 0.9% from last year’s revenue of $7.81 billion.
Analyst Ratings: Analysts seem relatively indifferent about Boston Scientific with 19 of 26 analysts surveyed maintaining a hold rating.
Revenue has fallen in the past four quarters. Revenue declined 1.8% to $1.93 billion in first quarter. The figure fell 3.7% in the fourth quarter of the last fiscal year from the year earlier, dropped 5.4% in third quarter of the last fiscal year from the year-ago quarter and 7% in the second quarter of the last fiscal year.
Competitors to Watch: Medtronic, Inc. (NYSE:MDT), St. Jude Medical, Inc. (NYSE:STJ), Merit Medical Systems, Inc. (NASDAQ:MMSI), C.R. Bard, Inc. (NYSE:BCR), Abbott Laboratories (NYSE:ABT), Johnson & Johnson (NYSE:JNJ), Stryker Corporation (NYSE:SYK), Teleflex Incorporated (NYSE:TFX), AngioDynamics, Inc. (NASDAQ:ANGO), and The Spectranetics Corp. (NASDAQ:SPNC).
Stock Price Performance: During June 13, 2011 to July 12, 2011, the stock price had risen 61 cents (9.1%) from $6.67 to $7.28. The stock price saw one of its best stretches over the last year between August 18, 2010, and August 26, 2010, when shares rose for seven-straight days, rising 10.2% (+55 cents) over that span. Shares have been on a negative streak of late, closing down every day between July 8, 2011 and July 12, 2011. Shares are down 29 cents (-3.8%) year to date.
(Source: Xignite Financials)
Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!